Results 81 to 90 of about 7,708 (214)

Additional file 1 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

open access: yes, 2022
Additional file 1: Table S1. Primers used for qRT-PCR in this study. Table S2. The clinical data of 15 prolactinoma patients. Table S3. siRNA used in this study. Table S4. Antibodies used in this study. Table S5.
Jing Guo (102972)   +7 more
core   +1 more source

Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma

open access: yes, 2010
P>ObjectiveObjective Although the strong association between hyperprolactinaemia and platelet aggregation is well recognized, there are no studies on changes in coagulation and fibrinolytic status in patients with prolactinoma.
Nuhoglu, Irfan   +4 more
core   +1 more source

Additional file 3 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

open access: yes, 2022
Additional file 3: Figure S2.SF3B1-R625H alters the transcriptome in GH3 cells and human prolactinoma. (A) Volcano plot comparing mRNA expression between Sf3b1 mutant vs. wild-type GH3 cells.
Jing Guo (102972)   +7 more
core   +1 more source

Breast abscess complicting prolactinoma

open access: yes, 2014
Prolactinoma is an intra-sellar benign adenoma. It could be micro- or macro-adenoma. The commoner micro-adenoma is an endocrine active. The distant effect of Prolactinaemia is on reproductive system and breast as seen in our Para-2 45 year old woman with
Motah, M, Uduma, F
core   +1 more source

Prolactinoma in Pregnancy

open access: yes, 2015
Power point of case of prolactinoma which became symptomatic during pregnancy with visual field loss. Discussion of prolactinomas and their management. Patient underwent observation only.
Timothy Sullivan, MD; Rudrani Banik, MD
core  

PRECLINICAL ATHEROSCLEROSIS IN PATIENTS WITH PROLACTINOMA

open access: yes, 2014
Objective: The aim of this study was to evaluate the effect of hyperprolactinemia on body fat, insulin sensitivity, inflammatory markers, and cardiovascular risk in patients with ...
Ucan, Bekir   +12 more
core   +1 more source

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

open access: yesIndian Journal of Endocrinology and Metabolism, 2017
Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare   +6 more
doaj   +1 more source

Granuloma hipofisario y prolactinoma

open access: yes, 2009
Cinco imágenes de un granuloma hipofisario y un prolactinoma.Five pictures of a pituitary granuloma and a ...
Iglesias Rozas, José Rafael, 1942-
core  

Giant Prolactinoma: Challenges in Management

open access: yes
Background/Objective: Prolactinomas are the most common form of pituitary adenomas, 90% of which are microprolactinomas measuring \u3c 1 cm. A giant prolactinoma is defined as a prolactinoma measuring \u3e4 cm with a serum prolactin level of \u3e1000 ng ...
Sharma, Sapna   +2 more
core   +1 more source

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

open access: yesFrontiers in Endocrinology
PurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy